| Name | Title | Contact Details |
|---|
Prestige Health Choice is a Fort Myers, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Beebe Medical Center, founded in 1916, is a not-for-profit community medical center governed by a volunteer Board of Trustees. Beebe has become the premier healthcare facility in Sussex County, serving a thriving beach and vacation resort area and a growing year-round population. Beebe provides comprehensive inpatient, outpatient, emergency, and home care in medical-surgical, obstetrics, pediatrics, oncology, and critical-care medicine. Outpatient services include an Outpatient Surgical Center, Diagnostic Imaging Centers, and Rehabilitation. Beebe Medical Center serves as a teaching facility for many regional allied health and professional education programs. Clinical practicums/experience are available in all continuums of care. Beebe Medical Center is fully accredited by the Joint Commission on Accreditation of Healthcare Organizations.
Healthcare Integrated Technologies, Inc. is focused on developing effective, non-intrusive, resident monitoring technologies for senior living communities. Healthcare Integrated Technologies is headquartered in Knoxville, Tennessee.
ianacare is the best way for family caregivers to get the help and practical support they need (meals, rides, respite care, child care, pet care, house errands) from the people in their social circles, community, and co-workers who want to help. Get St...
Ampio is an innovative drug discovery and development company combining scientific, regulatory, and business capabilities to efficiently develop a robust portfolio of novel therapeutic candidates. These therapeutic candidates, if approved, will address significant inflammatory conditions for which limited treatment options exist. Ampio’s therapeutic product pipeline has been developed through more than two decades of study at leading hospital-based research centers. Rigorous preclinical and clinical research efforts have yielded a diverse portfolio of late-stage product candidates focusing on the world’s most prevalent inflammatory conditions including osteoarthritis and diabetic macular edema. Significant discoveries in both basic science and clinical research have resulted in Ampio receiving over 180 patents throughout the world, with hundreds more pending. Further, hundreds of peer-reviewed publications, abstracts, and scientific presentations highlight the depth of research supporting Ampio’s therapeutic product candidates. Ampio’s leading product candidates are Ampion™ and Optina™. The company is currently conducting the second pivotal clinical trial in the US for Ampion, a biologic intra-articular injection being studied for the treatment of osteoarthritis of the knee. Ampio is also conducting a late-stage US clinical trial for Optina, an oral agent being studied for the treatment of diabetic macular edema. Millions of patients worldwide are affected by these conditions, for which limited treatment options exist. At Ampio, we strive to offer compelling therapeutic options for the patients most in need of new treatments, and we operate every day to advance our products’ development and make these available to patients.